应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
DXCM 德康医疗
未开盘 11-04 16:00:00 EST
88.48
+5.51
+6.64%
盘后
88.28
-0.20
-0.23%
19:57 EST
最高
88.96
最低
84.75
成交量
524.90万
今开
85.06
昨收
82.97
日振幅
5.07%
总市值
329.99亿
流通市值
329.15亿
总股本
3.73亿
成交额
4.63亿
换手率
1.41%
流通股本
3.72亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
异动解读|德康医疗盘中上涨5.42%,Q3业绩超预期并获上调目标价
行情直击 · 11-04 23:08
异动解读|德康医疗盘中上涨5.42%,Q3业绩超预期并获上调目标价
异动解读|德康医疗盘中上涨5.27%,财报超预期叠加目标价获上调
行情直击 · 10-30
异动解读|德康医疗盘中上涨5.27%,财报超预期叠加目标价获上调
财报前瞻 | 德康医疗本季度营收预计增12.56%,机构观点偏向看多
财报Agent · 10-22
财报前瞻 | 德康医疗本季度营收预计增12.56%,机构观点偏向看多
异动解读|德康医疗盘中下跌5.25%,财报前板块走弱中回吐近期看多预期
行情直击 · 10-21
异动解读|德康医疗盘中下跌5.25%,财报前板块走弱中回吐近期看多预期
异动解读|德康医疗盘中上涨5.2%,多家投行近期继续上调目标价
行情直击 · 10-15
异动解读|德康医疗盘中上涨5.2%,多家投行近期继续上调目标价
花旗重申医疗科技板块两大首选股:看好雅培业务复苏与德康医疗市场份额增长
环球市场播报 · 10-08
花旗重申医疗科技板块两大首选股:看好雅培业务复苏与德康医疗市场份额增长
Truist上调德康医疗目标价至102美元
格隆汇 · 09-21
Truist上调德康医疗目标价至102美元
异动解读|德康医疗盘中下跌5.01%,报82.58美元
行情直击 · 08-05
异动解读|德康医疗盘中下跌5.01%,报82.58美元
Canaccord Genuity上调德康医疗目标价至90美元
格隆汇 · 08-04
Canaccord Genuity上调德康医疗目标价至90美元
小摩上调德康医疗目标价至82美元
格隆汇 · 08-03
小摩上调德康医疗目标价至82美元
异动解读|德康医疗盘中上涨7.4%,Q2业绩全面超预期并上调全年营收指引
行情直击 · 07-31
异动解读|德康医疗盘中上涨7.4%,Q2业绩全面超预期并上调全年营收指引
异动解读|德康医疗盘前上涨6.65%,Q2业绩全面超预期并上调全年营收指引
行情直击 · 07-31
异动解读|德康医疗盘前上涨6.65%,Q2业绩全面超预期并上调全年营收指引
异动解读 | 德康医疗夜盘大涨8.18%,Q2业绩全面超预期并上调全年指引
异动解读 · 07-31
异动解读 | 德康医疗夜盘大涨8.18%,Q2业绩全面超预期并上调全年指引
德康医疗Q2业绩超预期,上调全年营收指引的下限
格隆汇 · 07-31
德康医疗Q2业绩超预期,上调全年营收指引的下限
异动解读 | 德康医疗夜盘大涨7.28%,Q2财报超预期并上调全年营收指引
异动解读 · 07-31
异动解读 | 德康医疗夜盘大涨7.28%,Q2财报超预期并上调全年营收指引
异动解读|德康医疗夜盘上涨7.28%,Q2业绩全面超预期并上调全年指引
行情直击 · 07-31
异动解读|德康医疗夜盘上涨7.28%,Q2业绩全面超预期并上调全年指引
异动解读 | 财报超预期并上调全年指引,德康医疗盘后大涨近6%
异动解读 · 07-31
异动解读 | 财报超预期并上调全年指引,德康医疗盘后大涨近6%
异动解读|德康医疗盘后上涨6.28%,Q2业绩全面超预期并上调全年指引
行情直击 · 07-31
异动解读|德康医疗盘后上涨6.28%,Q2业绩全面超预期并上调全年指引
德康医疗获选为首家参与FDA数字健康设备试点项目的企业
格隆汇 · 07-23
德康医疗获选为首家参与FDA数字健康设备试点项目的企业
异动解读|德康医疗盘中下跌5.06%,报70.97美元
行情直击 · 07-23
异动解读|德康医疗盘中下跌5.06%,报70.97美元
加载更多
公司概况
公司名称:
德康医疗
所属市场:
NASDAQ
上市日期:
--
主营业务:
德康医疗公司是一家于1999年5月在特拉华州注册成立的公司。该公司是一家医疗器械公司,主要专注于设计、开发和商业化连续血糖监测(CGM)系统,用于管理世界各地的患者、护理人员和临床医生的糖尿病。
发行价格:
--
{"stockData":{"symbol":"DXCM","market":"US","secType":"STK","nameCN":"德康医疗","latestPrice":88.48,"timestamp":1793826000000,"preClose":82.97,"halted":0,"volume":5249001,"hourTrading":{"tag":"盘后","latestPrice":88.28,"preClose":88.48,"latestTime":"19:57 EST","volume":595659,"amount":52703899.5897,"timestamp":1793840259252,"change":-0.2,"changeRate":-0.00226,"amplitude":0.007006},"delay":0,"changeRate":0.06640954561889846,"floatShares":372000000,"shares":372950922,"eps":2.550098,"marketStatus":"未开盘","change":5.51,"latestTime":"11-04 16:00:00 EST","open":85.06,"high":88.96,"low":84.751,"amount":462819377.82285,"amplitude":0.050729,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":2.550098,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1793869200000},"marketStatusCode":0,"adr":0,"adrRate":0,"listingDate":1113451200000,"exchange":"NASDAQ","adjPreClose":82.97,"preHourTrading":{"tag":"盘前","latestPrice":85.06,"preClose":82.97,"latestTime":"09:29 EST","volume":6336,"amount":536145.5404800001,"timestamp":1793802599999,"change":2.09,"changeRate":0.02519,"amplitude":0.041639},"postHourTrading":{"tag":"盘后","latestPrice":88.28,"preClose":88.48,"latestTime":"19:57 EST","volume":595659,"amount":52703899.5897,"timestamp":1793840259252,"change":-0.2,"changeRate":-0.00226,"amplitude":0.007006},"volumeRatio":0.93329,"impliedVol":0.4294,"impliedVolPercentile":0.2908},"requestUrl":"/m/hq/s/DXCM","defaultTab":"news","newsList":[{"id":"1186516205","title":"异动解读|德康医疗盘中上涨5.42%,Q3业绩超预期并获上调目标价","url":"https://stock-news.laohu8.com/highlight/detail?id=1186516205","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1186516205?lang=zh_cn&edition=full","pubTime":"2026-11-04 23:08","pubTimestamp":1793804908,"startTime":"0","endTime":"0","summary":"11月4日,德康医疗盘中上涨5.42%,报87.385美元,成交额5042.61万美元。此次异动的消息面,主要来自公司此前披露的第三季度业绩超预期、上调全年营收指引,以及机构上调目标价。公司第三季度调整后每股收益0.73美元,高于预期的0.67美元;营收13.44亿美元,高于预期的13.27亿美元,并将全年营收指引上调至52.0亿至52.5亿美元。最新研报还指出,公司美国市场份额提升、全球新增患者接近纪录水平,15天版G7传感器转换推进,增强了后续增长预期;巴克莱也将目标价上调至120美元。(以上内容均基于市场公开消息,由程序或算法智能生成,仅作为股价异动提醒,不作为投资建议或交易依据。)","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"德康医疗业绩超预期,盘中强势上涨","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DXCM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1136935955","title":"异动解读|德康医疗盘中上涨5.27%,财报超预期叠加目标价获上调","url":"https://stock-news.laohu8.com/highlight/detail?id=1136935955","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1136935955?lang=zh_cn&edition=full","pubTime":"2026-10-30 22:09","pubTimestamp":1793369386,"startTime":"0","endTime":"0","summary":"10月30日,德康医疗盘中上涨5.27%,报84.295美元,成交额1.66亿美元。消息面上,公司第三季度调整后每股收益0.73美元,高于市场预期的0.67美元;营收13.44亿美元,同比增长并高于预期的13.27亿美元。同时,公司将全年营收指引上调至52.0亿至52.5亿美元,前值为51.8亿至52.5亿美元。此外,最新消息显示,巴克莱将德康医疗目标价由115美元上调至120美元,进一步强化了业绩发布后的积极预期。(以上内容均基于市场公开消息,由程序或算法智能生成,仅作为股价异动提醒,不作为投资建议或交易依据。)","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"德康医疗盘中大涨,财报超预期目标价获上调","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DXCM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1140489696","title":"财报前瞻 | 德康医疗本季度营收预计增12.56%,机构观点偏向看多","url":"https://stock-news.laohu8.com/highlight/detail?id=1140489696","media":"财报Agent","labels":["earningPreview"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1140489696?lang=zh_cn&edition=full","pubTime":"2026-10-22 10:09","pubTimestamp":1792634998,"startTime":"0","endTime":"0","summary":"德康医疗将于2026年10月29日发布财报,市场聚焦营收增速与盈利弹性是否延续上季度超预期表现。一致预期显示,本季度德康医疗营收约13.27亿美元,同比增12.56%;调整后每股收益约0.67美元,同比增18.54%。上季度德康医疗营收13.08亿美元,同比增长13.08%;毛利率63.44%;归母净利润2.49亿美元;净利率19.04%;调整后每股收益0.70美元,同比增长45.83%。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"财报前瞻 | 德康医疗本季度营收预计增12.56%,机构观点偏向看多","news_tag":"earningPreview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DXCM"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"1193384987","title":"异动解读|德康医疗盘中下跌5.25%,财报前板块走弱中回吐近期看多预期","url":"https://stock-news.laohu8.com/highlight/detail?id=1193384987","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1193384987?lang=zh_cn&edition=full","pubTime":"2026-10-21 23:20","pubTimestamp":1792596053,"startTime":"0","endTime":"0","summary":"10月21日,德康医疗盘中下跌5.25%,报81.22美元/股,成交额1.47亿美元。公开消息面上,公司临近10月29日财报披露窗口,近期虽连续获投行上调目标价,但最新可见信息并无新增实质性利空。10月13日Mizuho将目标价由95美元上调至100美元,10月12日BTIG由90美元上调至96美元,10月7日Evercore ISI更由90美元上调至110美元,显示机构仍整体看好其中长期表现。不过当日医疗保健设备板块整体承压,雅培、史赛克、波士顿科学等均下跌,德康医疗跌幅更为明显。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"德康医疗盘中走弱,财报前板块承压","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DXCM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1197764411","title":"异动解读|德康医疗盘中上涨5.2%,多家投行近期继续上调目标价","url":"https://stock-news.laohu8.com/highlight/detail?id=1197764411","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1197764411?lang=zh_cn&edition=full","pubTime":"2026-10-15 22:16","pubTimestamp":1792073775,"startTime":"0","endTime":"0","summary":"10月15日,德康医疗盘中上涨5.2%,报87.59美元,成交额6738.6万美元。消息面上,近期投行继续上调公司目标价,强化市场对其后续增长与份额提升的预期。最新动态显示,瑞穗将目标价由95美元上调至100美元,BTIG将目标价由90美元上调至96美元;更早前Evercore ISI、RBC也分别上调至110美元、105美元。公司此前二季度业绩亦提供基本面支撑:当季调整后每股收益0.70美元、营收13.1亿美元,均高于预期,并上调全年营收指引下限至51.8亿美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"德康医疗盘中上涨,投行密集上调目标价","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DXCM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673218330","title":"花旗重申医疗科技板块两大首选股:看好雅培业务复苏与德康医疗市场份额增长","url":"https://stock-news.laohu8.com/highlight/detail?id=2673218330","media":"环球市场播报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2673218330?lang=zh_cn&edition=full","pubTime":"2026-10-08 15:26","pubTimestamp":1791444360,"startTime":"0","endTime":"0","summary":"花旗指出,德康医疗是当前医疗科技板块中经营增长动能最为明确的企业之一。相较于雅培CGM业务增长放缓,德康医疗正在通过产品更新、国际市场扩张和新增患者覆盖持续争夺市场份额。整体来看,花旗对医疗科技板块的投资判断更加侧重企业自身的增长确定性。雅培的主要看点在于低估值与CGM业务潜在复苏,德康医疗则已经通过营收增长、盈利能力改善及市场份额扩张展现出经营优势。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2026-10-08/doc-iniupaez7557135.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK4548","HEAL","IHI","SGXZ41872573.SGD","LU2468319806.SGD","FTXO","LU0234572021.USD","LU0098860793.USD","LU2237957811.SGD","LU1244550494.USD","BK4568","XLK","LU1670627923.USD","BK4533","GB00BDT5M118.USD","LU0052756011.USD","LU2112291526.USD","LU2433249047.HKD","LU1061106388.HKD","LU0868494617.USD","DXCM","IYF","LU2125909247.SGD","LU2324357040.USD","BK4207","EKG","IE00B2B36J28.USD","LU1721429741.USD","LU0354030511.USD","LU0203347892.USD","ARTY","159891","IE00BFTCPJ56.SGD","LU0130102774.USD","LU0211331839.USD","TMED","LU2210149790.SGD","ABT","LU2360032135.SGD","SG9999004303.SGD","IE00BJT1NW94.SGD","LU2417539215.USD","PJP","LU2125909593.SGD","IE0009355771.USD","TFNS","LU1691799644.USD","SGXZ23171101.USD","LU0070302665.USD","LU1989763690.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669131727","title":"Truist上调德康医疗目标价至102美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2669131727","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669131727?lang=zh_cn&edition=full","pubTime":"2026-09-21 11:23","pubTimestamp":1789961020,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["HEAL","LU2210150020.SGD","BK4588","UDN","LU0266013472.USD","IE00BMPRXR70.SGD","LU2433249047.HKD","UUP","LU1923622614.USD","LU2125909247.SGD","LU2125909593.SGD","BK4551","BK4534","BK4082","BK4548","DXCM","LU0354030511.USD","GB00BDT5M118.USD","LU2210149790.SGD","BK4585","IE00BMPRXN33.USD","LU2095319765.USD","LU2211815571.USD","LU0354030438.USD","BK4504","LU1323610961.USD","EKG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1178443325","title":"异动解读|德康医疗盘中下跌5.01%,报82.58美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1178443325","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1178443325?lang=zh_cn&edition=full","pubTime":"2026-08-05 23:59","pubTimestamp":1785945548,"startTime":"0","endTime":"0","summary":"8月5日,德康医疗盘中下跌5.01%,报82.58美元/股,成交额1.96亿美元。德康医疗所在的医疗保健设备行业中,个股普遍承压,其中直觉外科公司涨0.79%,银休特跌20.79%,波士顿科学跌3.03%,史赛克跌1.29%,雅培跌1.01%。(以上内容均基于市场公开消息,由程序或算法智能生成,仅作为股价异动提醒,不作为投资建议或交易依据。)","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DXCM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656352765","title":"Canaccord Genuity上调德康医疗目标价至90美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2656352765","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2656352765?lang=zh_cn&edition=full","pubTime":"2026-08-04 16:26","pubTimestamp":1785831999,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["UDN","LU0354030511.USD","LU1323610961.USD","LU1923622614.USD","LU2125909593.SGD","IE00BMPRXR70.SGD","BK4082","BK4548","LU0266013472.USD","HEAL","IE00BMPRXN33.USD","BK4551","LU2125909247.SGD","DXCM","BK4585","BK4504","LU2095319765.USD","LU2433249047.HKD","UUP","BK4534","LU2210150020.SGD","EKG","LU2211815571.USD","BK4588","LU0354030438.USD","LU2210149790.SGD","GB00BDT5M118.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656344493","title":"小摩上调德康医疗目标价至82美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2656344493","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2656344493?lang=zh_cn&edition=full","pubTime":"2026-08-03 10:32","pubTimestamp":1785724325,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["UDN","BK4551","LU0354030511.USD","LU1923622614.USD","BK4585","LU2095319765.USD","LU1323610961.USD","EKG","BK4082","BK4588","LU0354030438.USD","BK4504","IE00BMPRXR70.SGD","DXCM","BK4548","LU2211815571.USD","LU2125909593.SGD","LU0266013472.USD","LU2125909247.SGD","IE00BMPRXN33.USD","LU2433249047.HKD","LU2210149790.SGD","BK4534","UUP","GB00BDT5M118.USD","HEAL","LU2210150020.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1115554443","title":"异动解读|德康医疗盘中上涨7.4%,Q2业绩全面超预期并上调全年营收指引","url":"https://stock-news.laohu8.com/highlight/detail?id=1115554443","media":"行情直击","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1115554443?lang=zh_cn&edition=full","pubTime":"2026-07-31 21:42","pubTimestamp":1785505335,"startTime":"0","endTime":"0","summary":"7月31日,德康医疗盘中上涨7.4%,报81.86美元/股,成交额1.24亿美元。消息面上,公司发布第二季度财报,业绩全面超出市场预期并上调全年营收指引,成为股价上涨的核心催化剂。具体数据方面,Q2调整后每股收益0.70美元,大幅超越分析师一致预期的0.61美元,同比增长45.83%;营收13.08亿美元,超预期的12.90亿美元,同比增长约13%,主要得益于连续血糖监测仪的强劲需求。公司同时将全年营收指引上调至51.8亿至52.5亿美元,此前区间下限为51.6亿美元,进一步增强市场信心。(以上内容均基于市场公开消息,由程序或算法智能生成,仅作为股价异动提醒,不作为投资建议或交易依据。)","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DXCM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1142009053","title":"异动解读|德康医疗盘前上涨6.65%,Q2业绩全面超预期并上调全年营收指引","url":"https://stock-news.laohu8.com/highlight/detail?id=1142009053","media":"行情直击","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1142009053?lang=zh_cn&edition=full","pubTime":"2026-07-31 16:28","pubTimestamp":1785486517,"startTime":"0","endTime":"0","summary":"7月31日,德康医疗盘前上涨6.65%,报79.3美元/股。消息面上,公司盘后公布第二季度财报,业绩全面超出市场预期并上调全年营收指引,成为股价上涨的核心催化剂。具体数据方面,Q2调整后每股收益0.70美元,大幅超越分析师一致预期的0.61美元,同比增长45.83%;营收13.08亿美元,超预期的12.90亿美元,同比增长约13%。公司同时将全年营收指引上调至51.8亿至52.5亿美元,此前区间下限为51.6亿美元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DXCM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1191666434","title":"异动解读 | 德康医疗夜盘大涨8.18%,Q2业绩全面超预期并上调全年指引","url":"https://stock-news.laohu8.com/highlight/detail?id=1191666434","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1191666434?lang=zh_cn&edition=full","pubTime":"2026-07-31 15:04","pubTimestamp":1785481466,"startTime":"0","endTime":"0","summary":"德康医疗今日夜盘股价大涨8.18%,引发市场广泛关注。消息面上,公司盘后公布的季度财报表现亮眼,成为推动股价上涨的核心催化剂。得益于连续血糖监测仪的强劲需求,德康医疗第二季度营收达到13.1亿美元,同比增长约13%,高于分析师预期的12.9亿美元;调整后每股收益为0.70美元,大幅超越市场预期的0.61美元。同时,公司上调了全年营收指引,预计全年营收将在51.8亿美元至52.5亿美元之间,此前区间下限为51.6亿美元,进一步增强了市场信心。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["DXCM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655105333","title":"德康医疗Q2业绩超预期,上调全年营收指引的下限","url":"https://stock-news.laohu8.com/highlight/detail?id=2655105333","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2655105333?lang=zh_cn&edition=full","pubTime":"2026-07-31 10:18","pubTimestamp":1785464282,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["LU2095319765.USD","BK4548","IE00BMPRXR70.SGD","BK4551","BK4588","LU0354030438.USD","BK4585","EKG","DXCM","GB00BDT5M118.USD","LU2433249047.HKD","HEAL","LU2125909247.SGD","LU1323610961.USD","LU2125909593.SGD","LU0354030511.USD","IE00BMPRXN33.USD","BK4082","BK4504","LU0266013472.USD","LU2210149790.SGD","LU1923622614.USD","BK4534","LU2211815571.USD","LU2210150020.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1136962178","title":"异动解读 | 德康医疗夜盘大涨7.28%,Q2财报超预期并上调全年营收指引","url":"https://stock-news.laohu8.com/highlight/detail?id=1136962178","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1136962178?lang=zh_cn&edition=full","pubTime":"2026-07-31 08:08","pubTimestamp":1785456527,"startTime":"0","endTime":"0","summary":"德康医疗今日夜盘股价大涨7.28%,引发市场广泛关注。消息面上,公司盘后公布的季度业绩全面超出市场预期,并上调了全年营收指引,成为推动股价上涨的主要催化剂。得益于连续血糖监测仪的强劲需求,德康医疗第二季度营收达到13.1亿美元,同比增长13%,高于分析师预期的12.9亿美元;调整后每股收益为70美分,同样优于市场预期的61美分。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["DXCM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1100980673","title":"异动解读|德康医疗夜盘上涨7.28%,Q2业绩全面超预期并上调全年指引","url":"https://stock-news.laohu8.com/highlight/detail?id=1100980673","media":"行情直击","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1100980673?lang=zh_cn&edition=full","pubTime":"2026-07-31 08:04","pubTimestamp":1785456276,"startTime":"0","endTime":"0","summary":"7月31日,德康医疗夜盘上涨7.28%,报79.97美元/股。消息面上,公司盘后公布第二季度财报,业绩全面超出市场预期,并上调全年营收指引,成为股价上涨的核心催化剂。具体数据方面,Q2调整后每股收益0.70美元,大幅超越分析师一致预期的0.61美元,同比增长45.83%;营收13.08亿美元,超预期的12.90亿美元,同比增长约13%。公司同时将全年营收指引上调至51.8亿至52.5亿美元,此前区间下限为51.6亿美元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"德康医疗夜盘上涨7.28%,Q2业绩全面超预期并上调全年指引","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DXCM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1114316127","title":"异动解读 | 财报超预期并上调全年指引,德康医疗盘后大涨近6%","url":"https://stock-news.laohu8.com/highlight/detail?id=1114316127","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1114316127?lang=zh_cn&edition=full","pubTime":"2026-07-31 04:37","pubTimestamp":1785443841,"startTime":"0","endTime":"0","summary":"德康医疗(Dexcom,DXCM)今日盘后股价大涨5.98%,引发市场关注。消息面上,公司盘后公布的季度业绩超出市场预期,并上调了全年营收指引,成为股价上涨的主要催化剂。得益于连续血糖监测仪的强劲需求,德康医疗第二季度营收达13.1亿美元,同比增长13%,高于分析师预期的12.9亿美元;调整后每股收益为70美分,同样优于市场预期的61美分。公司还预计全年营收将在51.8亿美元至52.5亿美元之间,较此前指引有所上调,分析师平均预期为52.2亿美元。随着糖尿病护理意识提升以及消费者对无创监测技术的偏好增加,连续血糖监测仪市场需求持续旺盛,推动德康医疗等龙头厂商的业绩表现与市场信心。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["DXCM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1104022685","title":"异动解读|德康医疗盘后上涨6.28%,Q2业绩全面超预期并上调全年指引","url":"https://stock-news.laohu8.com/highlight/detail?id=1104022685","media":"行情直击","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1104022685?lang=zh_cn&edition=full","pubTime":"2026-07-31 04:36","pubTimestamp":1785443798,"startTime":"0","endTime":"0","summary":"7月31日,德康医疗盘后上涨6.28%,报78.07美元/股,成交额2080.01万美元。消息面上,公司发布第二季度财报,业绩全面超出市场预期。Q2调整后每股收益0.70美元,大幅超越分析师一致预期的0.61美元,同比增长45.83%;营收13.08亿美元,超预期的12.90亿美元,同比增长约12.9%。同时公司上调全年营收指引至51.8亿至52.5亿美元,此前区间下限为51.6亿美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DXCM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653515716","title":"德康医疗获选为首家参与FDA数字健康设备试点项目的企业","url":"https://stock-news.laohu8.com/highlight/detail?id=2653515716","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2653515716?lang=zh_cn&edition=full","pubTime":"2026-07-23 13:18","pubTimestamp":1784783902,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BK4082","GB00BDT5M118.USD","BK4585","LU2095319765.USD","LU2125909247.SGD","LU2125909593.SGD","LU2210149790.SGD","HEAL","EKG","LU1923622614.USD","LU2211815571.USD","BK4588","LU0354030438.USD","LU0266013472.USD","BK4504","LU2210150020.SGD","LU0354030511.USD","LU1323610961.USD","BK4548","LABU","BK4534","IE00BMPRXR70.SGD","DXCM","LU2433249047.HKD","BK4551","IE00BMPRXN33.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1137865548","title":"异动解读|德康医疗盘中下跌5.06%,报70.97美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1137865548","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1137865548?lang=zh_cn&edition=full","pubTime":"2026-07-23 03:35","pubTimestamp":1784748922,"startTime":"0","endTime":"0","summary":"7月22日,德康医疗盘中下跌5.06%,报70.97美元/股,成交额1.45亿美元。德康医疗所在的医疗保健设备行业中,板块整体表现偏弱,个股中,直觉外科公司跌2.39%,雅培涨0.55%,史赛克跌1.32%,波士顿科学跌0.86%,爱德华兹跌0.48%。德康医疗是一家医疗器械公司,主要专注于设计、开发和商业化连续血糖监测(CGM)系统,用于管理全球患者、护理人员和临床医生的糖尿病,公司定于7月30日发布第二季度财报。(以上内容均基于市场公开消息,由程序或算法智能生成,仅作为股价异动提醒,不作为投资建议或交易依据。)","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DXCM"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.dexcom.com;investors.dexcom.com","stockEarnings":[{"period":"1week","weight":0.1254},{"period":"1month","weight":0.0182},{"period":"3month","weight":0.0658},{"period":"6month","weight":0.4598},{"period":"1year","weight":0.4462},{"period":"ytd","weight":0.3331}],"compareEarnings":[{"period":"1week","weight":-0.0071},{"period":"1month","weight":-0.0104},{"period":"3month","weight":-0.0023},{"period":"6month","weight":0.0396},{"period":"1year","weight":0.1356},{"period":"ytd","weight":0.1245}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"德康医疗公司是一家于1999年5月在特拉华州注册成立的公司。该公司是一家医疗器械公司,主要专注于设计、开发和商业化连续血糖监测(CGM)系统,用于管理世界各地的患者、护理人员和临床医生的糖尿病。","yearOnYearQuotes":[{"month":1,"riseRate":0.714286,"avgChangeRate":0.06713},{"month":2,"riseRate":0.428571,"avgChangeRate":0.005394},{"month":3,"riseRate":0.571429,"avgChangeRate":0.008909},{"month":4,"riseRate":0.571429,"avgChangeRate":0.053795},{"month":5,"riseRate":0.590909,"avgChangeRate":0.039223},{"month":6,"riseRate":0.727273,"avgChangeRate":0.051799},{"month":7,"riseRate":0.454545,"avgChangeRate":-0.003842},{"month":8,"riseRate":0.772727,"avgChangeRate":0.083627},{"month":9,"riseRate":0.272727,"avgChangeRate":-0.04239},{"month":10,"riseRate":0.363636,"avgChangeRate":-0.032337},{"month":11,"riseRate":0.590909,"avgChangeRate":0.034745},{"month":12,"riseRate":0.571429,"avgChangeRate":0.046062}],"exchange":"NASDAQ","name":"德康医疗","nameEN":"DexCom"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.52.0","shortVersion":"4.52.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"德康医疗(DXCM)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供德康医疗(DXCM)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"德康医疗,DXCM,德康医疗股票,德康医疗股票老虎,德康医疗股票老虎国际,德康医疗行情,德康医疗股票行情,德康医疗股价,德康医疗股市,德康医疗股票价格,德康医疗股票交易,德康医疗股票购买,德康医疗股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"德康医疗(DXCM)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供德康医疗(DXCM)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}